Published Study Demonstrated Once-Daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII Provided Significant …

Published August 9, 2010

Published Study Demonstrated Once-Daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII Provided Significant …
PHILADELPHIA, Aug. 5 /PRNewswire-FirstCall/ — Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder (ADHD) who took once-daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in …
Read more on redOrbit

The rocky path from skid row to redemption
From spartan rooms provided by Project 50, which targeted the hard-core homeless in downtown L.A., one man dreamed of regaining lost wealth, the other of returning to his life on the sea. From the day they pulled him off the pavement, Paul Sigler, a haunted-looking man with striking pale blue eyes, presented a mystery to Carrie Bach’s team. He wasn’t like the rest of the skid row crowd, he …
Read more on Los Angeles Times

Getting to the root of DUI problems
Officers stop cars to ask if drivers have been drinking during a DUI and driver’s license checkpoint on Petaluma Boulevard Friday night.
Read more on The Petaluma Argus-Courier